UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of Losartan and Platinum Nanoparticles with Photothermal Therapy Induces Immunogenic Cell Death Effective Against Neuroblastoma

International journal of nanomedicine, 2024-01, Vol.19, p.10213-10226

2024

Volltextzugriff (PDF)

Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats

Journal of cellular and molecular medicine, 2015-08, Vol.19 (8), p.1965-1974

2015

Volltextzugriff (PDF)

Serum Concentrations of Losartan Metabolites Correlate With Improved Physical Function in a Pilot Study of Prefrail Older Adults

The journals of gerontology. Series A, Biological sciences and medical sciences, 2022-12, Vol.77 (12), p.2356-2366

2022

Volltextzugriff (PDF)

The effect of topical ramipril and losartan cream in inhibiting scar formation

Biomedicine & pharmacotherapy, 2019-10, Vol.118, p.109394-109394, Article 109394

2019

Volltextzugriff (PDF)

Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents

Molecules (Basel, Switzerland), 2022-01, Vol.27 (3), p.864

2022

Volltextzugriff (PDF)

Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors

Cancer biotherapy & radiopharmaceuticals, 2024-06, Vol.39 (5), p.337-348

2024

Volltextzugriff (PDF)

Reduction of Aversive Learning Rates in Pavlovian Conditioning by Angiotensin II Antagonist Losartan: A Randomized Controlled Trial

Biological psychiatry (1969), 2024-08, Vol.96 (4), p.247-255

2024

Volltextzugriff (PDF)

The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review

Osteoarthritis and cartilage, 2023-04, Vol.31 (4), p.435-446

2023

Volltextzugriff (PDF)

Spatial and single-cell transcriptome analysis reveals changes in gene expression in response to drug perturbation in rat kidney

DNA research, 2022-02, Vol.29 (2)

2022

Volltextzugriff (PDF)

Evaluation of pharmacokinetic herb-drug interaction of diabecon and losartan by UHPLC-MS/MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-09, Vol.1245, p.124267, Article 124267

2024

Volltextzugriff (PDF)

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Clinical cancer research, 2022-02, Vol.28 (4), p.662-676

2022

Volltextzugriff (PDF)

Changes in Glycated Human Serum Albumin Binding Affinity for Losartan in the Presence of Fatty Acids In Vitro Spectroscopic Analysis

Molecules (Basel, Switzerland), 2022-01, Vol.27 (2), p.401

2022

Volltextzugriff (PDF)

Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2024-08, Vol.245, p.116160-116160, Article 116160

2024

Volltextzugriff (PDF)

Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea

American journal of respiratory and critical care medicine, 2016-02, Vol.193 (3), p.310-320

2016

Volltextzugriff (PDF)

The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan

International journal of molecular sciences, 2017-09, Vol.18 (9), p.1980

2017

Volltextzugriff (PDF)

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

The New England journal of medicine, 2009-07, Vol.361 (1), p.40-51

2009

Volltextzugriff (PDF)

Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells

European journal of pharmacology, 2023-05, Vol.946, p.175650-175650, Article 175650

2023

Volltextzugriff (PDF)

Physical exercise is essential for increasing ventricular contractility in hypertensive rats treated with losartan

Hypertension research, 2024-05, Vol.47 (5), p.1350-1361

2024

Volltextzugriff (PDF)

Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy

Kidney international, 2008-08, Vol.74 (3), p.364-369

2008

Volltextzugriff (PDF)

Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia

Molecular neurobiology, 2019-11, Vol.56 (11), p.7408-7419

2019

Volltextzugriff (PDF)

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

The New England journal of medicine, 2013-11, Vol.369 (20), p.1892-1903

2013

Volltextzugriff (PDF)

The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in rat

European journal of pharmacology, 2020-09, Vol.882, p.173229, Article 173229

2020

Volltextzugriff (PDF)

Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats

Drug and chemical toxicology (New York, N.Y. 1978), 2020-09, Vol.43 (5), p.468-478

2020

Volltextzugriff (PDF)

Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial

European heart journal, 2020-11, Vol.41 (43), p.4181-4187

2020

Volltextzugriff (PDF)

1 – 25 von 5.865

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.675)
Mit Volltextzugriff
(5.154)

Publikationsform

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.865)
Male
(3.463)
Animals
(3.195)
Losartan
(2.777)
Humans
(2.552)
Losartan - Pharmacology
(2.319)
Rats
(2.186)
Biological And Medical Sciences
(2.108)
Cardiovascular System & Cardiology
(1.870)
Medical Sciences
(1.725)
Female
(1.712)
Losartan - Therapeutic Use
(1.610)
Pharmacology & Pharmacy
(1.477)
Angiotensin Receptor Antagonists
(1.306)
Blood Pressure - Drug Effects
(1.282)
Peripheral Vascular Disease
(1.282)
Hypertension - Drug Therapy
(1.086)
Middle Aged
(1.048)
Angiotensin Ii
(1.045)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.436)
IngentaConnect Journals
(3.275)
EZB Electronic Journals Library
(2.983)
Journals@Ovid
(2.905)
IngentaConnect Journals
(1.556)
Elsevier ScienceDirect Journals Complete
(1.237)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.009)
Single Journals
(852)
Wiley Online Library All Journals
(634)
Wiley Online Library
(494)
SpringerLink Journals - AutoHoldings
(464)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(342)
Oxford journals
(319)
Oxford Journals 2020 Medicine
(282)
Taylor & Francis Journals
(270)
Taylor & Francis
(259)
Taylor & Francis Online
(242)
Nature Journals Online
(202)
SAGE Journals
(155)
Nexis Uni
(150)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Combination of Losartan and Platinum Nanoparticles with Photothermal Therapy Induces Immunogenic Cell Death Effective Against Neuroblastoma

Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats

Serum Concentrations of Losartan Metabolites Correlate With Improved Physical Function in a Pilot Study of Prefrail Older Adults

The effect of topical ramipril and losartan cream in inhibiting scar formation

Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents

Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors

Reduction of Aversive Learning Rates in Pavlovian Conditioning by Angiotensin II Antagonist Losartan: A Randomized Controlled Trial

The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review

Spatial and single-cell transcriptome analysis reveals changes in gene expression in response to drug perturbation in rat kidney

Evaluation of pharmacokinetic herb-drug interaction of diabecon and losartan by UHPLC-MS/MS

Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma

Changes in Glycated Human Serum Albumin Binding Affinity for Losartan in the Presence of Fatty Acids In Vitro Spectroscopic Analysis

Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometry

Blood Pressure Response to Losartan and Continuous Positive Airway Pressure in Hypertension and Obstructive Sleep Apnea

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial

The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells

Physical exercise is essential for increasing ventricular contractility in hypertensive rats treated with losartan

Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy

Losartan, an Angiotensin II Type 1 Receptor Antagonist, Alleviates Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain by Inhibiting Inflammatory Cytokines in the Dorsal Root Ganglia

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in rat

Protective effects of combined Losartan and Nilotinib on carbon tetrachloride (CCl4)-induced liver fibrosis in rats

Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial

Aktive Filter

Suchergebnisse filtern